FASN, MAP2 and BMP6 were highly expressed in bladder cancer, while GPC2, CNOT6L, GALNT12 and CARD10 were expressed at low levels in bladder cancer (Fig. 3F). Here, CNOT6L is linked to urinary bladder carcinoma.